Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of the Use of Refrigerant Helmet to Prevent Alopecia in Patients Treated With Eribulin for Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Female patient who has a locally advanced or metastatic breast cancer~* Indication of Halaven treatment :~patient pretreated with anthracyclines or taxanes, patient who has received at least 1 chemotherapy regimen for their advanced or metastatic stage~* Patient who has had enough time to have retrieved her hair or whose last chemotherapy regimen didn't induce alopecia.~* Aged ≥ 18 years~* Non-opposition of the patient must have been collected~Exclusion Criteria:~* Skin metastasis of the scalp~* Sensitivity to cold, cold agglutinin disease or cryoglobulinemia~* Impossibility to submit at the study procedures due to geographic, social or mental reasons

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).